Dividend Action: Anthem, Inc. (NYSE:ANTM) advises to “Mark your calendars” for Dec 21, 2016; dividends expected to reach $0.65.

Dividend Action: Anthem, Inc. (NYSE:ANTM) advises to

Anthem, Inc. (NYSE:ANTM) is expected to pay $0.65 on Dec 21, 2016. The indicated annual dividend is $2.60. Shareholders owning the stock before Dec 1, 2016 will be eligible to receive the payout. Based on Anthem, Inc.’s current price of $145.28, the dividend is 0.45%. This dividend’s record date is Dec 5, 2016 and the announcement date is Nov 2, 2016. The stock increased 1.42% or $2.04 during the last trading session, hitting $145.28. Anthem Inc (NYSE:ANTM) has risen 0.36% since April 27, 2016 and is uptrending. It has underperformed by 4.87% the S&P500.

Anthem, Inc. is a health benefit company. The company has a market cap of $37.88 billion. The Firm offers a range of network managed care plans to large and small employer, individual, Medicaid and Medicare markets. It has a 17.05 P/E ratio. The Firm has three divisions: Commercial and Specialty Business, Government Business and Other.

Anthem Inc (NYSE:ANTM) Ratings Coverage

Out of 15 analysts covering Anthem Inc (NYSE:ANTM), 7 rate it a “Buy”, 0 “Sell”, while 8 “Hold”. This means 47% are positive. $224 is the highest target while $133 is the lowest. The $165.20 average target is 13.71% above today’s ($145.28) stock price. Anthem Inc has been the topic of 23 analyst reports since July 27, 2015 according to StockzIntelligence Inc. The stock of Anthem Inc (NYSE:ANTM) has “Buy” rating given on Friday, April 8 by Cleveland. On Friday, January 8 the stock rating was maintained by Jefferies with “Buy”. As per Monday, April 4, the company rating was maintained by Leerink Swann. The company was upgraded on Tuesday, November 15 by Wells Fargo. The firm has “Buy” rating by Goldman Sachs given on Wednesday, January 20. The firm has “Hold” rating by Jefferies given on Tuesday, September 13. On Thursday, July 30 the stock rating was maintained by Oppenheimer with “Outperform”. On Monday, July 27 the stock rating was upgraded by Sterne Agee CRT to “Buy”. The company was initiated on Thursday, June 16 by Bernstein. The rating was initiated by Citigroup with “Buy” on Friday, October 2.

More recent Anthem Inc (NYSE:ANTM) news were published by: Bloomberg.com which released: “Anthem Threatens Obamacare Retreat If Results Don’t Improve” on November 02, 2016. Also Reuters.com published the news titled: “Anthem argues Fortune 500 will not suffer from Cigna deal” on November 21, 2016. Wsj.com‘s news article titled: “Anthem Begins Defense of Cigna Merger at Antitrust Trial” with publication date: November 29, 2016 was also an interesting one.

ANTM Company Profile

Anthem, Inc., incorporated on July 17, 2001, is a health benefit company. The Firm offers a range of network managed care plans to large and small employer, individual, Medicaid and Medicare markets. The Firm has three divisions: Commercial and Specialty Business, Government Business and Other. The Company’s Commercial and Specialty Business, and Government Business divisions offer managed care products, including preferred well-known provider organizations (PPOs), health maintenance organizations (HMOs), traditional indemnity benefits and point-of-service (POS) plans, as well as various hybrid benefit plans, including consumer-driven health plans (CDHPs), hospital only and limited benefit products. In addition, the Company also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, well-known provider network access, medical cost management, disease management, wellness programs and other administrative services. The Firm provides an array of specialty and other insurance services and products, such as dental, vision, life and disability insurance benefits, radiology benefit management and analytics-driven personal healthcare. The Firm also provides services to the federal government in connection with the Federal Employee Program (FEP).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment